TrialAntimicrobial agents and chemotherapy2013

Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase.

Martijn Fenaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.